Turner, Tia H <br/><br/>
Identification of synergistic drug combinations using breast cancer patient-derived xenografts.  [electronic resource] 

 -  Scientific reports  01 2020 
 - 1493 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2045-2322 
<br/><br/><label>Standard No.: </label>10.1038/s41598-020-58438-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Afatinib--administration & dosage<br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Carboplatin--administration & dosage<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Dose-Response Relationship, Drug<br/>Drug Screening Assays, Antitumor<br/>Drug Synergism<br/>ErbB Receptors--antagonists & inhibitors<br/>Female<br/>Humans<br/>Imidazoles--administration & dosage<br/>Mice<br/>Mice, Inbred NOD<br/>Mice, SCID<br/>Naphthoquinones--administration & dosage<br/>Oligopeptides--administration & dosage<br/>Survivin--antagonists & inhibitors<br/>Triple Negative Breast Neoplasms--drug therapy<br/>Xenograft Model Antitumor Assays